Dylan Rosser

Executive Director, Global Development Operations
Amgen
 

 

Dylan has over 25 years of clinical research experience gained from working in the CRO and bio-pharmaceutical sectors across a wide range of therapeutic areas.

Dylan initially joined Amgen’s nephrology team following which he transitioned to lead early phase oncology studies in Europe. After several years supporting Medical Affairs in Switzerland, Dylan rejoined development to lead the regional late phase oncology team in the US. Since then, Dylan has led Amgen’s bone, neuroscience, and inflammation program management therapeutic areas. In recent years Dylan has led several acquisitions for development and currently heads up the business operations functions in global development operations.

Dylan has also led several large technology solution initiatives in clinical operations and is currently championing the development and delivery of decentralized clinical trial methodologies to better serve patients and clinical researchers.